HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
NEOG
Neogen Corp
Healthcare Diagnostics & Research · Michigan, USA · Reports in usd
Market Cap: $2.07B
Market Cap
$2.07B
Enterprise Val
$2.70B
P/E Ratio
-3.40
P/B Ratio
0.98
Trailing PEG (1Y)
-0.06
As Of
Apr 21, 2026

Overview & Key Metrics

Reporting period: Feb 28, 2026 · Q3 2026
Book Value$2.10B
Gross Margin46.88%
Profit Margin46.88%
Return on Equity-29.00%
Return on Assets-17.98%
Current Ratio3.92
Debt/Equity0.38
LT Debt/Equity0.38
Revenue Per Share0.97

Income Statement

Feb 28, 2026
Revenue$211.2M
Cost of Revenue$112.2M
Gross Profit$99.0M
R&D$3.8M
SG&A$98.5M
Operating Expenses$102.3M
Operating Income-$3.3M
Interest Expense$13.9M
Tax Expense-$3.3M
Net Income-$17.0M
EPS (Basic)$-0.08
EPS (Diluted)$-0.08
EBIT-$6.4M
EBITDA$22.5M
Consolidated Income-$17.0M
Non-Controlling Interests$0.00

Balance Sheet

Feb 28, 2026
Cash & Equivalents$159.9M
Accounts Receivable$137.1M
Inventory$161.7M
Current Assets$590.0M
LT Investments$0.00
Property, Plant & Equipment$347.6M
Intangibles$2.39B
Non-Current Assets$2.77B
Total Assets$3.36B
Accounts Payable$75.2M
Current Debt$0.00
Current Liabilities$150.6M
LT Debt$793.3M
Non-Current Liabilities$1.11B
Total Liabilities$1.26B
Total Debt$793.3M
Retained Earnings-$533.0M
Shareholder Equity$2.10B
Shares Outstanding217,525,981

Cash Flow Statement

Feb 28, 2026
Operating Cash Flow$22.7M
Investing Cash Flow-$11.6M
Financing Cash Flow$744.0K
CapEx-$11.5M
Free Cash Flow$11.2M
Depreciation & Amort.$28.9M
Stock-Based Comp$1.1M
Acquisitions / Disposals-$24.0K
Investment Activity$0.00
Debt Issued/Repaid-$25.0K
Equity Issued/Repaid$822.0K
Dividends Paid$0.00
Net Change in Cash$14.6M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h